MENU

Ocular Therapeutix (OCUL) Ownership - Who owns Ocular Therapeutix?

Profile

Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.23B
P/E Ratio
N/A
Total Cash
482.89M
Projected Growth
N/A
Total Debt
74.41M
Revenue
59.84M
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash/Share
3.12
Total Debt/Equity
N/A
Revenue/Share
0.60 USD as % of share price

Fundamentals

OCUL
Capitalization
1.23B
P/E Ratio
N/A
Risk (Beta)
1.08
Dividend Yield
N/A
Total Cash
483M
Total Cash/Share
3.12
Total Debt
74.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.60%
Revenue
59.8M
ROE
N/A
Book Value
408M
P/B Ratio
3.06
Cash Flow
N/A
Earnings
-1.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
15K
Current Ratio
21.39
Current Revenue Per Employee
55333.33
Dividends Per Share - Security
N/A
EBITDA
-98.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
91.02
Revenue To Assets
-34.54
Shares Held By Institutions
1.12B
Shares Outstanding - Current
155M
Total Liabilities
131M
Total Volume MTD
N/A
Value
N/A
Gain YTD
77.354
View a ticker or compare two or three
OCUL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com